title: Lovastatin treatment of hyperlipidemia in kidney transplant recipients on cyclosporine immunosuppression.
authors.affiliation: Department of Nephrology, University Medical Centre, Ljubljana, Slovenia.
authors.forename: A
authors.initials: A
authors.lastname: Kandus
authors.forename: D
authors.initials: D
authors.lastname: Kovac
authors.forename: M
authors.initials: M
authors.lastname: Koselj
authors.forename: R
authors.initials: R
authors.lastname: Kveder
authors.forename: A F
authors.initials: AF
authors.lastname: Bren
mesh_terms: D000328:Adult; D002784:Cholesterol / Q000097:blood*; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D016572:Cyclosporine / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced* / Q000188:drug therapy*; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008148:Lovastatin / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged
chemical_list: D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D016572:Cyclosporine; D002784:Cholesterol; D008148:Lovastatin